Amusing – COLY was grilled on today’s CC about animal-tox issues just because ANDS has had such issues in their HCV program and both companies’ drugs belong to the general class of Toll-like receptor agonists.
COLY said they have had no problems whatsoever with animal tox.
Market Data 
Markets 
AI
